Clinical

Dataset Information

Personalized use of irinotecan in colorectal cancer patients based on real world studies and pharmacogenomics


ABSTRACT: Interventions: Wild-type group:None;Single heterozygous group:None;Mutant homozygous/double heterozygous group:None Primary outcome(s): Efficacy;The incidence of adverse events Study Design: Cohort study

DISEASE(S): Colorectal Cancer

PROVIDER: 89703 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR